These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29985194)

  • 1. Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery.
    Zencirkiran Agus H; Uygur B; Guler A; Demirci G; Kalkan AK; Yildiz M
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):559-561. PubMed ID: 29985194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus.
    Yildiz M; Karakoyun S; Acar RD; Ozkan M
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
    Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful catheter-directed thrombolysis of a massive pulmonary embolism in a patient after recent pneumonectomy.
    Lee KS; Sista AK; Friedman OA; Horowitz JM; Port JL; Madoff DC
    Clin Imaging; 2015; 39(1):140-3. PubMed ID: 25457536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early lytic treatment of massive pulmonary embolism.
    Cardiovasc J S Afr; 2002; 13(4):218-9. PubMed ID: 12402933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
    Mele M; Mele A; La Torre PP; Cannone M
    G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolysis in pulmonary embolism].
    Thabut G; Jebrak G
    Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of alteplase in pulmonary embolism treatment].
    Malinovskiĭ NN; Gruzdev AK; Beskaeva LM; Sal' nikov DV; Nikerov KIu; Abramov AS; Fineshin IN
    Khirurgiia (Mosk); 2008; (7):4-7. PubMed ID: 18833155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
    Raskob GE
    Curr Opin Pulm Med; 1995 Jul; 1(4):291-7. PubMed ID: 9363067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis of venous and arterial thrombosis by catheter-directed low-dose infusion of tissue plasminogen activator in children.
    Cannizzaro V; Berger F; Kretschmar O; Saurenmann R; Knirsch W; Albisetti M
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):688-91. PubMed ID: 16344680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic thrombolysis for acute pulmonary embolism.
    Bartel B
    Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The PEITHO study].
    Alunni G; Coen D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):591-5. PubMed ID: 25424135
    [No Abstract]   [Full Text] [Related]  

  • 13. [The place of lysis in acute pulmonary embolism].
    Olschewski H
    Zentralbl Chir; 2006 Oct; 131(5):432-4. PubMed ID: 17089298
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism.
    Güner A; Kalçik M; Aykan AÇ; Gürsoy MO; Kalkan AK; Astarcioğlu MA; Ertürk M; Uzun F; Güner EG; Yildiz M; Özkan M
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):536-542. PubMed ID: 33181758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor.
    Han S; Chaya C; Hoo GW
    J Intensive Care Med; 2006; 21(4):240-5. PubMed ID: 16855059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Massive pulmonary embolism, thrombus in transit, and right ventricular dysfunction].
    Santos Martínez LE; Uriona Villarroel JE; Exaire Rodríguez JE; Mendoza D; Martínez Guerra ML; Pulido T; Bautista E; Castañón A; Sandoval J
    Arch Cardiol Mex; 2007; 77(1):44-53. PubMed ID: 17500192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of regional right ventricular function after thrombolysis for pulmonary embolism.
    Nass N; McConnell MV; Goldhaber SZ; Chyu S; Solomon SD
    Am J Cardiol; 1999 Mar; 83(5):804-6, A10. PubMed ID: 10080447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified thrombolytic therapy for massive pulmonary emboli.
    Arsanjani R; Goldman S; Habib MP; Movahed MR
    Am J Med; 2011 Aug; 124(8):e7-8. PubMed ID: 21658666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS
    Klin Med (Mosk); 2004; 82(10):4-8. PubMed ID: 15584590
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Berlin DA
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.